Trademark Overview
On Thursday, September 11, 2025, a trademark application was filed for LYCIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LYCIA THERAPEUTICS trademark a serial number of 99387673. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 11, 2025. This trademark is owned by Lycia Therapeutics, Inc.. The LYCIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therape...
